Trial Profile
A real-world, retrospective, long-term study to evaluate the efficacy and safety of Vedolizumab in patients with Inflammatory Bowel Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 May 2019
Price :
$35
*
At a glance
- Drugs Vedolizumab (Primary)
- Indications Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis
- Focus Therapeutic Use
- Acronyms The Cross Pennine study
- 18 Jan 2018 New trial record